AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32915972 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine plus ibrutinib
Number of subjects: 144
Study 34496274 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture-taking feature of the food diary app
Number of subjects: 0
Study 34496274 — intervention group
Group type: COMPARATOR
Intervention: No picture-taking feature (control)
Number of subjects: 0
Study 34250945 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 255
Study 34250945 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 255
Study 32031096 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Next group (continuous rotary system)
Number of subjects: 60
Study 32031096 — intervention group
Group type: COMPARATOR
Intervention: WaveOne group (reciprocating instruments)
Number of subjects: 60
Study 32031096 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34432263 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised online functional imagery training (FIT) over 2 weeks
Number of subjects: 52
Study 34432263 — intervention group
Group type: COMPARATOR
Intervention: Standard risk information about binge drinking at university (Control)
Number of subjects: 52
Study 32187119 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR+
Number of subjects: 98
Study 32187119 — intervention group
Group type: COMPARATOR
Intervention: SMH
Number of subjects: 98
Study 36215061 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation training
Number of subjects: 137
Study 36215061 — intervention group
Group type: COMPARATOR
Intervention: Non-native language training
Number of subjects: 137
Study 36215061 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 137
Study 32931712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 916
Study 32931712 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 916
Study 32822676 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose CT (CT) screening
Number of subjects: 449
Study 32822676 — intervention group
Group type: COMPARATOR
Intervention: Chest radiography (CXR) screening
Number of subjects: 449
Study 32822676 — intervention group
Group type: COMPARATOR
Intervention: SEER cohort (general population)
Number of subjects: 449
Study 32822676 — intervention group
Group type: EXPERIMENTAL
Intervention: CT arm
Number of subjects: 449
Study 32822676 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumor size below median of 17 mm
Number of subjects: 449
Study 32822676 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection vs. full resection
Number of subjects: 449
Study 32822676 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment vs. full resection
Number of subjects: 449
Study 36316826 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic formulation with 3 billion CFU (Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus)
Number of subjects: 0
Study 36316826 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic formulation with 8 billion CFU (Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus paracasei, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus casei, Bifidobacterium animallis)
Number of subjects: 0
Study 36316826 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32943750 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomustine in combination with idarubicin and cytarabine
Number of subjects: 330
Study 32943750 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy without lomustine
Number of subjects: 330
Study 35000532 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing sparing intensity modulated radiotherapy (SW‐IMRT)
Number of subjects: 146
Study 35000532 — intervention group
Group type: COMPARATOR
Intervention: Standard parotid sparing intensity-modulated radiotherapy (ST‐IMRT)
Number of subjects: 146
Study 35361026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg tds for days 1-7, then 8 mg od for days 8-21)
Number of subjects: 334
Study 35361026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study 32752178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 supplementation (LG, 3 × 10^10 CFU/day)
Number of subjects: 0
Study 32752178 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 0
Study 32752178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 supplementation (LG)
Number of subjects: 0
Study 35685605 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvogyl
Number of subjects: 60
Study 35685605 — intervention group
Group type: EXPERIMENTAL
Intervention: mixture of Nigella sativa's powder and oil
Number of subjects: 60
Study 35685605 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 60
Study 33260268 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatments
Number of subjects: 557
Study 33260268 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatments
Number of subjects: 557
Study 33260268 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help strategies
Number of subjects: 557
Study 33260268 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines
Number of subjects: 557
Study 33687180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical insufflation/exsufflation (MI/E) with expiratory flow accelerator (EFA) technology
Number of subjects: 30
Study 33687180 — intervention group
Group type: COMPARATOR
Intervention: Mechanical insufflation/exsufflation (MI/E) only
Number of subjects: 30
Study 33687180 — intervention group
Group type: COMPARATOR
Intervention: Both groups (EFA and MI/E only)
Number of subjects: 30
Study 33047455 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF 300 mg every 48 hours
Number of subjects: 46
Study 33047455 — intervention group
Group type: COMPARATOR
Intervention: TDF 300 mg every 72 hours
Number of subjects: 46
Study 32791677 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-guided educational technology intervention
Number of subjects: 60
Study 32791677 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 60
Study 33449095 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use at least 3 times/week
Number of subjects: 139896
Study 33449095 — intervention group
Group type: EXPERIMENTAL
Intervention: Any aspirin use
Number of subjects: 139896
Study 33449095 — intervention group
Group type: COMPARATOR
Intervention: Aspirin use
Number of subjects: 139896
Study 32907456 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture Button (SB)
Number of subjects: 113
Study 32907456 — intervention group
Group type: COMPARATOR
Intervention: Syndesmotic Screw (TS)
Number of subjects: 113
Study 35660440 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous no-till (NT)
Number of subjects: 0
Study 35660440 — intervention group
Group type: COMPARATOR
Intervention: Chisel-disk (CD)
Number of subjects: 0
Study 34154394 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 93
Study 34154394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 35604746 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person, office-based bCBCT (OB-bCBCT)
Number of subjects: 0
Study 35604746 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telehealth bCBCT (HB-bCBCT)
Number of subjects: 0
Study 35604746 — intervention group
Group type: COMPARATOR
Intervention: In-person psychoeducation comparison condition (PTSD family education [OB-PFE])
Number of subjects: 0
Study 35604746 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (OB-bCBCT, HB-bCBCT, OB-PFE)
Number of subjects: 0
Study 32382083 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐CHOP (Alemtuzumab plus CHOP)
Number of subjects: 116
Study 32382083 — intervention group
Group type: COMPARATOR
Intervention: CHOP (Control)
Number of subjects: 116
Study 35984171 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit training with low-carbohydrate diet (CTE + LC diet)
Number of subjects: 70
Study 35984171 — intervention group
Group type: COMPARATOR
Intervention: Circuit training (CTE)
Number of subjects: 70
Study 34467636 — intervention group
Group type: EXPERIMENTAL
Intervention: Suchana intervention
Number of subjects: 0
Study 32867982 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymol
Number of subjects: 2000
Study 32867982 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvacrol
Number of subjects: 2000
Study 32867982 — intervention group
Group type: EXPERIMENTAL
Intervention: Euganol
Number of subjects: 2000
Study 32867982 — intervention group
Group type: COMPARATOR
Intervention: Control (without EOs)
Number of subjects: 2000
Study 36053286 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-consumer-style PRS report for 5 common complex conditions
Number of subjects: 84
Study 36053286 — intervention group
Group type: COMPARATOR
Intervention: Control information
Number of subjects: 84
Study 35096758 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 3172
Study 35096758 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 3172
Study 35778479 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of coconut oil/day
Number of subjects: 44
Study 35778479 — intervention group
Group type: COMPARATOR
Intervention: Diet therapy
Number of subjects: 44
Study 35778479 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet therapy and 20 mL of coconut oil/day
Number of subjects: 44
Study 34872303 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling (FSN) therapy
Number of subjects: 60
Study 34872303 — intervention group
Group type: COMPARATOR
Intervention: Massage therapy
Number of subjects: 60
Study 32464832 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 80
Study 32464832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33693552 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 vaccines
Number of subjects: 0
Study 33465369 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS-guided DK crush stenting
Number of subjects: 556
Study 33465369 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided DK crush stenting
Number of subjects: 556
Study 32885298 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-CCRT ADC50
Number of subjects: 58
Study 32885298 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-CCRT delineation and feature repeatability
Number of subjects: 58
Study 32885298 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-CCRT repeatability
Number of subjects: 58
Study 32885298 — intervention group
Group type: EXPERIMENTAL
Intervention: All features except for T2WKurtosis
Number of subjects: 58
Study 32078966 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CBT and sertraline
Number of subjects: 319
Study 32078966 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 319
Study 32078966 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 319
Study 32078966 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 319
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Public insurance or uninsured status
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience of intimate partner violence
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of living children
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger maternal age
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of pregnancies
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Transportation difficulties
Number of subjects: 0
Study 33279734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of insurance and public insurance
Number of subjects: 0
Study 33376568 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate injections of rocuronium after propofol administration (Group PRi)
Number of subjects: 100
Study 33376568 — intervention group
Group type: COMPARATOR
Intervention: Delayed rocuronium injections when BIS decreased to <60 after propofol administration (Group PRd)
Number of subjects: 100
Study 33376568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRi and PRd)
Number of subjects: 100
Study 34076892 — intervention group
Group type: EXPERIMENTAL
Intervention: PREPARE website plus an easy-to-read advance directive (AD)
Number of subjects: 986
Study 34076892 — intervention group
Group type: COMPARATOR
Intervention: AD only
Number of subjects: 986
Study 34076892 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (PREPARE and AD only)
Number of subjects: 986
Study 32858313 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 119
Study 32858313 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 119
Study 35871088 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing delivered cognitive behavior therapy (VCBT) weekly over a 10-week period
Number of subjects: 78
Study 35871088 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 78
Study 33762635 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use alone (Subs)
Number of subjects: 3914
Study 33762635 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric symptomatology alone (Psych)
Number of subjects: 3914
Study 33762635 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbidity (Com)
Number of subjects: 3914
Study 33762635 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain meQTL of the Subs-associated SNPs
Number of subjects: 3914
Study 33762635 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain meQTL of the Psych-associated SNPs
Number of subjects: 3914
Study 33139629 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Fermentable Oligo‐, Di‐and Mono‐saccharides And Polyols (FODMAP) Diet (LFD)
Number of subjects: 0
Study 33139629 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten Free Diet (GFD)
Number of subjects: 0
Study 35560631 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted condition (24-hrs postprandial)
Number of subjects: 18
Study 35560631 — intervention group
Group type: COMPARATOR
Intervention: Fed condition (3-hrs postprandial)
Number of subjects: 18
Study 33984593 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzheng Jiedu Xiaoji formulation (FZJDXJ) combined with TACE
Number of subjects: 291
Study 33984593 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (Control)
Number of subjects: 291
Study 32652307 — intervention group
Group type: EXPERIMENTAL
Intervention: Fork-tip needle
Number of subjects: 129
Study 32652307 — intervention group
Group type: EXPERIMENTAL
Intervention: Franseen needle
Number of subjects: 129
Study 32652307 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylet retraction
Number of subjects: 129
Study 32652307 — intervention group
Group type: EXPERIMENTAL
Intervention: No suction
Number of subjects: 129
Study 32652307 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic mass larger than 3 cm
Number of subjects: 129
Study 34496619 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (treated group in MaRISS)
Number of subjects: 1736
Study 34496619 — intervention group
Group type: COMPARATOR
Intervention: No alteplase (non-treated group in MaRISS)
Number of subjects: 1736
Study 34496619 — intervention group
Group type: COMPARATOR
Intervention: PRISMS (randomized group)
Number of subjects: 1736
Study 33339304 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (600 IU daily)
Number of subjects: 436
Study 33339304 — intervention group
Group type: COMPARATOR
Intervention: Enhanced vitamin D2 in a mushroom matrix (D2M)
Number of subjects: 436
Study 33339304 — intervention group
Group type: COMPARATOR
Intervention: Standard mushroom (SM)
Number of subjects: 436
Study 33339304 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 436
Study 34715650 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-OSU6162 30-60 mg/day for 12 weeks
Number of subjects: 96
Study 34715650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 34715650 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-OSU6162 with concomitant antidepressants
Number of subjects: 96
Study 34715650 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-OSU6162 with beta- or calcium-channel blockers
Number of subjects: 96
Study 33189635 — intervention group
Group type: EXPERIMENTAL
Intervention: Serelaxin
Number of subjects: 0
Study 33189635 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study 36413549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge message reminding people of familial support
Number of subjects: 0
Study 36413549 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nudge message)
Number of subjects: 0
Study 34221620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) - 20 mg/kg bolus over 20 min followed by 1 mg/kg/h infusion until surgical wound closure
Number of subjects: 91
Study 34221620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 34221620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 91
Study 32702748 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin therapy
Number of subjects: 58390
Study 32702748 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin dose and other risk factors
Number of subjects: 58390
Study 32702748 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopathy risk score
Number of subjects: 58390
Study 32702748 — intervention group
Group type: EXPERIMENTAL
Intervention: SLCO1B1 genotype
Number of subjects: 58390
Study 34289183 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85
Number of subjects: 75
Study 34494112 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based diet plus eggs (2 eggs daily)
Number of subjects: 35
Study 34494112 — intervention group
Group type: COMPARATOR
Intervention: Exclusively plant-based diet (without eggs)
Number of subjects: 35
Study 36228177 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing Order Entry (SOE) to prescribe PP-CSF (n = 542)
Number of subjects: 846
Study 36228177 — intervention group
Group type: COMPARATOR
Intervention: Alert to not prescribe PP-CSF (n = 304)
Number of subjects: 846
Study 36228177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SOE and Alert)
Number of subjects: 846
Study 33322949 — intervention group
Group type: EXPERIMENTAL
Intervention: Baska Mask
Number of subjects: 60
Study 33322949 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 60
Study 35584804 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency whole-body vibration (WBV) at 4, 8, 12, 16, 24, and 30 Hz
Number of subjects: 20
Study 35584804 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency whole-body vibration (WBV)
Number of subjects: 20
Study 34235906 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-SCTG harvesting (test group)
Number of subjects: 16
Study 34235906 — intervention group
Group type: COMPARATOR
Intervention: Macro-SCTG harvesting (control group)
Number of subjects: 16
Study 35810822 — intervention group
Group type: EXPERIMENTAL
Intervention: Varied context group (VARI)
Number of subjects: 49
Study 35810822 — intervention group
Group type: COMPARATOR
Intervention: Constant context group (CONS)
Number of subjects: 49
Study 33148972 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine (6.4 g·d‐1 for 8 wk)
Number of subjects: 15
Study 33148972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33148972 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine
Number of subjects: 15
Study 32285513 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial dementia care programme (DEMBASE®)
Number of subjects: 157
Study 32285513 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators identified
Number of subjects: 157
Study 32285513 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers identified
Number of subjects: 157
Study 33239521 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopaedic-specific question prompt list (QPL) with 45 total questions
Number of subjects: 156
Study 33239521 — intervention group
Group type: COMPARATOR
Intervention: AskShareKnow model questions (control)
Number of subjects: 156
Study 35070226 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Wenjing decoction combined with online publicity and education
Number of subjects: 111
Study 35070226 — intervention group
Group type: COMPARATOR
Intervention: Online publicity and education and conventional treatment (Control)
Number of subjects: 111
Study 33031175 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target 130-140 mmHg)
Number of subjects: 1311
Study 33031175 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (<180 mmHg)
Number of subjects: 1311
Study 36037752 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HIRT) twice weekly for 12 weeks (group A)
Number of subjects: 71
Study 36037752 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HIRT) once weekly for 12 weeks (group B)
Number of subjects: 71
Study 36037752 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HIRT groups (A and B)
Number of subjects: 71
Study 36037752 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group (n=69)
Number of subjects: 71
Study 32600858 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolysed formula (pHF) with reduced lactose content and Lactobacillus reuteri DSM 17938 (L. reuteri)
Number of subjects: 241
Study 32600858 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 241
Study 35895362 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose azithromycin
Number of subjects: 0